قالب وردپرس درنا توس
Home / Business / Investing $1,000 in these 3 stocks would be a good choice

Investing $1,000 in these 3 stocks would be a good choice



Since the recent turmoil in the stock market has not given people a warm and vague feeling, some investors may choose to go to the mountains. The number of COVID-19 cases (the main reason behind this fluctuation) is likely to get worse before getting better.

However, savvy investors understand that the market volatility we are seeing often brings huge buying opportunities. You don’t even need a lot of preliminary preparation to get started. The key is to buy the right stocks, but which stocks look attractive? I think it would be a wonderful move to invest $1,000 in these three stocks now.

Woman showing a bag of money with thought bubble

Image source: Getty Images.

1. Curaleaf Holdings

Since the beginning of the COVID-19 pandemic, several industries have achieved impressive growth. You may be surprised to learn that the US cannabis industry is one of them. However, the US pot market is still in its infancy. Curaleaf Holdings (OTC: CURLF) Based on market capitalization, the company is the largest multi-state cannabis operator and is expected to continue to grow.

Curaleaf’s revenue surged by 120% in the second quarter, reaching an all-time high. The company is not yet profitable, but its bottom line is definitely to move in the right direction to achieve this goal soon. With the vigorous development of the company’s business, the stock has risen by more than 35% year-to-date.

In the short term, the stronger growth seems to be dunks. Since the end of the second quarter, Curaleaf has completed three acquisitions, including a huge acquisition of Grassroots, the largest vertically integrated multi-state private operator of cannabis in the United States. The company has also opened seven new retail cannabis bases in multiple states.

Curaleaf may be a huge winner on election day next week. Residents of Arizona and New Jersey voted to legalize recreational marijuana. Changing the control of the U.S. Senate and the White House may also lay the foundation for changing federal laws that open more markets and make Kolalev listed on a major U.S. stock exchange.

If Curaleaf’s election results go well, its share should soar. Even if not, the company still has great growth prospects.

2. Trade station

Trade station (Nasdaq stock code: TTD) As some companies reduced their advertising expenditures, they suffered business interruptions during the pandemic. Since the company is a leading provider of digital advertising platforms, it has a negative impact on The Trade Desk’s financial performance.

Will the deterioration of the coronavirus outbreak still hurt the Ministry of Trade? Maybe. However, this is only a temporary problem.

Jeff Green, CEO of Trade Service, said in August that he and his team “believe that the COVID pandemic has permanently accelerated the development of connected TV and changed the landscape of the TV industry forever.” He added: “No company can grab CTV’s share more than The Trade Desk.”

My opinion is that The Trade Desk is a good investment regardless of whether the stock retracements. The growth of CTV has produced long-term disadvantages. Remember that despite the impact of COVID-19, the stock of The Trade Desk has more than doubled so far this year. I think it still has enough room to run.

3. Trupanion

pan 09.30 NASDAQ: TRUP Is the fastest growing cat and dog medical insurance provider. During the coronavirus outbreak, the company’s pace of development has been maintained. Trupanion’s revenue increased by 28% year-on-year in the second quarter, and its adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) increased by more than five times.

In the long run, the COVID-19 pandemic may improve Trupanion’s growth prospects. how about it? As more and more Americans stay at home, the number of pets has increased significantly. But even without the help of the pandemic, the chances of Trupannion look great.

There are approximately 180 million cats and dogs in North America, and approximately 120 million cats and veterinarians each year. In the United States, only 1% of pets and nearly 2% of pets in Canada have medical insurance. In contrast, 25% of pets in the UK are insured. If Trupanion can achieve the same level of market penetration in the United States as in the United Kingdom, the company’s potential market will exceed $33 billion.

Trupanion should be in a good position to continue to expand its market share, thanks in large part to its close relationship with veterinarians throughout North America. I predict that this stock will become a huge winner in the next ten years.




Source link